The AI Orchestration Layer for Clinical Trials. From Protocol to Closeout.
Innovo Copilot is clinical trial AI software for sponsors and CROs. Role-trained AI agents plan studies, author documents, and monitor trial data, connected to your EDC, CTMS, and eTMF.
"The Innovo platform provides the executive-level visibility we need to ensure our global trials remain on schedule and compliant in every region."
"InnovoClinical has fundamentally changed how we manage our site relationships. The efficiency gains in study startup were visible within the first quarter of deployment."
"InnovoClinical has redefined how we manage our site partnerships. The improvements in study startup efficiency became clear within the very first quarter of implementation.”
60,000+
Global Sites
800+
Global Trials
300,000+
Global Users
Trial Complexity Is Outpacing the Tools Built to Manage It.
Clinical trials today involve increasing regulatory requirements, complex protocols, and growing operational demands across global study sites. Organizations need smarter, more efficient ways to streamline processes, reduce delays, and accelerate study execution.
-
Protocol Complexity
Design gaps in complex protocols lead to amendments and deviations that ripple through every downstream study document.
-
Study Startup Delays
Fragmented systems and manual handoffs stall the path to first-patient-in.
-
Site Engagement Issues
Disconnected communication and heavy document burden leave sites slow to respond and hard to support.
-
Monitoring Inefficiencies
Without central monitoring across sponsor and CRO systems, risks surface late and oversight stays reactive.
The FDA found it.
Why didn't we?
The trial lifecycle was built as a sequence of handoffs, not a system, and intelligence is lost at every one. The regulatory bar has moved: oversight must be risk-based and technology-enabled.
Risk-based, quality-by-design oversight
The first GCP overhaul in three decades — explicitly embracing modern technology, data governance, and risk-based monitoring across the trial.
AI must be credible & risk-assessed
The FDA’s first framework for AI in drug development sets a risk-based bar for the credibility of any model that informs a regulatory decision.
The Solution
One agent layer across the whole trial
A single layer of AI agents reasoning across every process, every source, and every system so intelligence never gets lost in the handoff.
Plan → Author → Monitor
Every phase feeds the next. Intelligence accumulates across the trial lifecycle rather than resetting at each handoff.
Plan
“We amended three times. What were we designing against?”
Evidence & feasibility, before you design. Design grounded in evidence from prior trials, real-world data, literature, and your own organizational memory.
- Synthesizes prior trials, real-world data & literature
- Validates I/E criteria against patient populations
- 300M+ records for feasibility validation
- Delivers a structured, evidence-grounded synopsis
Author
"We spent a million dollars fixing something that should never have been in the protocol."
Protocols, plans & documents governed. AI‑backed drafting turns governance from a six‑week bottleneck into convergence.
- Evidence-backed drafting with AI QC agents
- Auto-drafts ICF, CRF & DMP from approved protocol
- Generates RACT, TMP & SMP from the protocol
- Amendment cascade push changes to every related doc
Monitor
"When did you know the trial was off track, and why are we only hearing about it now?"
Risk-based, live, protocol-aware oversight. Oversight that surfaces risk as it emerges tied to its timeline impact, with the right action attached.
- One live site-risk score across EDC / CTMS / eTMF
- Breach → CAPA → verified closure, automatically
- Role-based dashboards grounded in the plan
- Every insight references the exact TMP / SMP section
One protocol. Every plan. Actionable intelligence. End to end.
Want to learn more about how clinical AI capabilities can supercharge your clinical operations? Contact us today with our “Request a Demo” form or email us at info@innovocommerce.com for more information. Our team is ready to answer your queries and help you make an informed decision.